SOURCE: Your Cancer Today

April 05, 2007 15:00 ET

When Cancer Comes Back; This Week on Your Cancer Today™

NEWPORT BEACH, CA -- (MARKET WIRE) -- April 5, 2007 -- In the last couple of weeks, we heard news of prominent people battling cancer recurrence; the wife of a candidate for President facing a return of her breast cancer, a Presidential Spokesperson hearing that his colon cancer has spread to his liver.

When cancer returns after a period of remission, it is considered a recurrence. With the diagnosis of a recurrence comes the shock, the fear and distress that plagued a patient the first time around. We explore cancer recurrence this week and talk about treatment options.

While on the subject of recurring cancer, we'll hear about a study which successfully used a new drug to battle recurrent brain tumors, or gliomas.

We'll also learn about an enlightening program for cancer surviving women that helps move those women quickly and powerfully beyond their cancer experience and back into living well.

Your Cancer Today™ is a 30-minute television talk show, dedicated to inform and educate viewers from both the institutional and patients' perspectives.

Your Cancer Today™ Producer Alan Painter is a Director of NanoLife Sciences, Inc. developers of Proton Treatment Centers. "This is a much needed show," Painter says, "and way overdue. Information is the key to fighting cancer and the more we can spread the word, the better it will be for everyone." Donald Baillargeon, Executive Producer and Host of MoneyTV, which has been running since 1996 in 125 million homes globally, is also the Host and Executive Producer of Your Cancer Today™. Your Cancer Today™ is seen throughout the United States on broadcast, cable and satellite television as well as in Western Europe. A full channel lineup is available at the company web site, http://www.yourcancertoday.com, which allows online viewing of past episodes on demand and is under construction for the provision of further information and investigation of various cancer treatments, alternatives and research being conducted.

Contact Information